Interestingly, high PYGO2 expression has also been shown to positively correlate with earlier PSA biochemical recurrence, indicating PYGO2 may also prove to be a valuable predictive biomarker for prostate cancer [97]. The gene discussed is PYGO2; the disease is prostate carcinoma.